Literature DB >> 14975181

The redox states of serum and synovial fluid of patients with temporomandibular joint disorders.

Mihoko Tomida1, Jun-Ichi Ishimaru, Tomoya Hayashi, Koji Nakamura, Koichi Murayama, Seiichi Era.   

Abstract

The redox states of albumin in serum and synovial fluid (SF) were analyzed in 35 female patients with temporomandibular joint disorders and 9 asymptomatic female healthy volunteers by high-performance liquid chromatographic (HPLC) analysis. Human serum albumin (HSA) is divided by HPLC analysis into three fractions: mercaptalbumin (HMA, reduced form) and nonmercaptalbumin (HNA-1 and HNA-2, oxidized forms). It was found that the characterized values of albumin in SF of patients with the disorders were the fraction of HMA (f (HMA), 65.8 +/- 9.1%), the fraction of HNA-1 (f (HNA-1), 31.3 +/- 8.8%), and the fraction of HNA-2 (f (HNA-2), 2.9 +/- 0.9%), respectively, and similarly the values of albumin in serum of same subjects were f (HMA), 79.4 +/- 4.0%; f (HNA-1), 18.7 +/- 3.8%; and f (HNA-2), 1.9 +/- 0.5%. The HNA fractions in SF were significantly higher than those in serum (p < 0.0001). The SF of patients and even control showed more oxidative condition compared with sera of the same subjects. Each fraction of SF showed significant difference in control (p < 0.05), and greater significance in patients (p < 0.0001). Furthermore, the HNA-2 fraction (f (HNA-2), 2.9 +/- 0.9%) in SF of the patients with temporomandibular joint disorders revealed a significantly higher value (p < 0.01) than that (f (HNA-2), 1.7 +/- 0.3%) of controls. These findings suggested that SF of the temporomandibular joint is more locally oxidized than serum; thus oxidative factors are concerned in the pathogenesis of the temporomandibular joint disorders. It was also suggested that synovial albumin may play a scavenging role against the intraarticular oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14975181     DOI: 10.2170/jjphysiol.53.351

Source DB:  PubMed          Journal:  Jpn J Physiol        ISSN: 0021-521X


  6 in total

1.  Difference in redox status of serum and aqueous humor in senile cataract patients as monitored via the albumin thiol-redox state.

Authors:  Kenji Kawai; Tomoya Hayashi; Yukie Matsuyama; Takeshi Minami; Seiichi Era
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

2.  Human astrocytes and aortic endothelial cells actively convert the oxidized form of albumin to the reduced form: reduced albumin might participate in redox regulation of nerve and blood vessel systems.

Authors:  Yukie Matsuyama; Tomoya Hayashi; Hiroyuki Terawaki; Tsuneo Negawa; Tomoyoshi Terada; Yukio Okano; Seiichi Era
Journal:  J Physiol Sci       Date:  2009-03-10       Impact factor: 2.781

3.  Oxidized human serum albumin as a possible correlation factor for atherosclerosis in a rural Japanese population: the results of the Yakumo Study.

Authors:  Ryosuke Fujii; Jun Ueyama; Arisa Aoi; Naohiro Ichino; Keisuke Osakabe; Keiko Sugimoto; Koji Suzuki; Nobuyuki Hamajima; Kenji Wakai; Takaaki Kondo
Journal:  Environ Health Prev Med       Date:  2018-01-02       Impact factor: 3.674

Review 4.  Minireview on the Connections between the Neuropsychiatric and Dental Disorders: Current Perspectives and the Possible Relevance of Oxidative Stress and Other Factors.

Authors:  Alin Ciobica; Manuela Padurariu; Alexandrina Curpan; Iulia Antioch; Roxana Chirita; Cristinel Stefanescu; Alina-Costina Luca; Mihoko Tomida
Journal:  Oxid Med Cell Longev       Date:  2020-06-30       Impact factor: 6.543

5.  New Predictors for Advanced Retinopathy of Prematurity among Neonates in Tehran/Iran.

Authors:  Karim Poorsattar Bejeh Mir; Parisa Mohagheghi; Arash Poorsattar Bejeh Mir; Seyed-Mohammad Fereshtehnejad
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

6.  Serum oxidized albumin and cardiovascular mortality in normoalbuminemic hemodialysis patients: a cohort study.

Authors:  Paik Seong Lim; Yachung Jeng; Ming Ying Wu; Mei-Ann Pai; Tsai-Kun Wu; Chia-San Liu; Chan Hsu Chen; Yuan-Chuan Kuo; Shiaw-Wen Chien; Hung Ping Chen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.